Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCollPlant Biotechnologies Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2026 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2027 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q3 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2027 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q1 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q2 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q3 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2028 | 1 | -$0.04 | -$0.04 | -$0.04 |
CollPlant Biotechnologies Ltd Earnings Date And Information
CollPlant Biotechnologies Ltd last posted its earnings results on Friday, May 29th, 2026. The company reported $-0.23 earnings per share for the quarter, topping analysts' consensus estimates of $-0.2374 by $0.0074. The company had revenue of 73.00 K for the quarter and had revenue of 2.37 M for the year. CollPlant Biotechnologies Ltd has generated $-1 earnings per share over the last year ($-0.94 diluted earnings per share) and currently has a price-to-earnings ratio of -0.32. CollPlant Biotechnologies Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
CollPlant Biotechnologies Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/29/2026 | Q1 2026 | -$0.24 | -$0.23 | 0.01 | $460.00 K | $73.00 K |
| 03/26/2026 | Q4 2025 | -$0.30 | -$0.25 | 0.05 | $2.08 M | $60.00 K |
| 11/26/2025 | Q3 2025 | $0.38 | -$0.27 | -0.65 | $4.84 M | $77.00 K |
| 08/20/2025 | Q2 2025 | -$0.10 | -$0.28 | -0.18 | $2.54 M | $179.00 K |
| 05/28/2025 | Q1 2025 | -$0.37 | -$0.13 | 0.24 | $2.65 M | $2.06 M |
| 03/26/2025 | Q4 2024 | -$0.42 | -$0.34 | 0.08 | $100.00 K | $164.00 K |
| 11/27/2024 | Q3 2024 | -$0.28 | -$0.38 | -0.1 | $416.00 K | $4.00 K |
| 08/20/2024 | Q2 2024 | -$0.35 | -$0.37 | -0.02 | $395.50 K | $249.00 K |
| 04/04/2024 | Q1 2024 | $0.24 | -$0.37 | -0.61 | $642.00 K | $98.00 K |
| 04/04/2024 | Q4 2023 | $0.24 | -$0.41 | -0.65 | N/A | $299.00 K |
| 11/29/2023 | Q3 2023 | -$0.13 | -$0.38 | -0.25 | N/A | $43.00 K |
| 06/30/2023 | Q2 2023 | N/A | $0.51 | N/A | N/A | $10.18 M |
| 05/24/2023 | Q1 2023 | -$0.29 | -$0.35 | -0.06 | N/A | $433.00 K |
| 03/29/2023 | Q4 2022 | -$0.21 | -$0.37 | -0.16 | N/A | $58.00 K |
| 12/01/2022 | Q3 2022 | -$0.31 | -$0.39 | -0.08 | N/A | $109.00 K |
| 06/30/2022 | Q2 2022 | N/A | -$0.40 | N/A | N/A | $66.00 K |
| 05/26/2022 | Q1 2022 | -$0.14 | -$0.37 | -0.23 | N/A | $66.00 K |
| 12/31/2021 | Q4 2021 | N/A | -$0.35 | N/A | N/A | $310.00 K |
| 11/18/2021 | Q3 2021 | -$0.28 | -$0.29 | -0.01 | N/A | $140.00 K |
| 06/30/2021 | Q2 2021 | N/A | -$0.30 | N/A | N/A | $691.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CollPlant Biotechnologies Ltd Earnings: FAQ's
In the previous quarter, CollPlant Biotechnologies Ltd (:CLGN) reported $-0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.2374 by $0.0074.
The conference call for CollPlant Biotechnologies Ltd's latest earnings report can be listened to online.
The conference call transcript for CollPlant Biotechnologies Ltd's latest earnings report can be read online.
CollPlant Biotechnologies Ltd (:CLGN) has a recorded annual revenue of $2.37 M.
CollPlant Biotechnologies Ltd (:CLGN) has a recorded net income of $-11,489,000.CollPlant Biotechnologies Ltd has generated $-0.94 earnings per share over the last four quarters.
CollPlant Biotechnologies Ltd (:CLGN) has a price-to-earnings ratio of -0.32 and price/earnings-to-growth ratio is -0.02.